Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadeem A Sheikh

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Methods (San Diego, Calif.)|September 27, 2003
Guns, genes, and spleen: a coming of age for rational vaccine designNadeem A Sheikh, W John W Morrow
Biomaterials|September 27, 2002
The ultrastructure of tomatine adjuvantYa-Wun Yang, Nadeem A Sheikh, W J W Morrow
Expert Review of Vaccines|June 5, 2007
Smart adjuvantsClint S Schmidt, W John W Morrow, Nadeem A Sheikh
Cureus|October 10, 2017
Intraoperative Awareness and Recall: A Comparative Study of Dexmedetomidine and Propofol in Cardiac SurgeryTufail Ahmad, Nadeem A Sheikh, Nihida Akhter, et al.
Expert Review of Clinical Pharmacology|August 10, 2013
Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcomeDebraj Guhathakurta, Nadeem A Sheikh, T Craig Meagher, et al.
Journal of the National Cancer Institute|February 25, 2021
Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target AntigensAdam S Kibel, Brant A Inman, Russell K Pachynski, et al.
Journal of the National Cancer Institute|April 5, 2017
Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer TreatmentJames L Gulley, Ravi A Madan, Russell Pachynski, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 14, 2020
Fecaloma presenting as huge abdominal massMushtaq A Khan, Hilal A Dar, Altaf H Shah, et al.
Cancer Immunology Research|September 24, 2020
Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-TLi Zhang, Harini Kandadi, Hai Yang, et al.
Vaccine|August 19, 2003
Differential requirements for CTL generation by novel immunostimulants: APC tropism, use of the TAP-independent processing pathway, and dependency on CD80/CD86 costimulationNadeem A Sheikh, George S Attard, Nico van Rooijen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Methods (San Diego, Calif.)|September 27, 2003
Guns, genes, and spleen: a coming of age for rational vaccine designNadeem A Sheikh, W John W Morrow
Biomaterials|September 27, 2002
The ultrastructure of tomatine adjuvantYa-Wun Yang, Nadeem A Sheikh, W J W Morrow
Expert Review of Vaccines|June 5, 2007
Smart adjuvantsClint S Schmidt, W John W Morrow, Nadeem A Sheikh
Cureus|October 10, 2017
Intraoperative Awareness and Recall: A Comparative Study of Dexmedetomidine and Propofol in Cardiac SurgeryTufail Ahmad, Nadeem A Sheikh, Nihida Akhter, et al.
Expert Review of Clinical Pharmacology|August 10, 2013
Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcomeDebraj Guhathakurta, Nadeem A Sheikh, T Craig Meagher, et al.
Journal of the National Cancer Institute|February 25, 2021
Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target AntigensAdam S Kibel, Brant A Inman, Russell K Pachynski, et al.
Journal of the National Cancer Institute|April 5, 2017
Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer TreatmentJames L Gulley, Ravi A Madan, Russell Pachynski, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 14, 2020
Fecaloma presenting as huge abdominal massMushtaq A Khan, Hilal A Dar, Altaf H Shah, et al.
Cancer Immunology Research|September 24, 2020
Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-TLi Zhang, Harini Kandadi, Hai Yang, et al.
Vaccine|August 19, 2003
Differential requirements for CTL generation by novel immunostimulants: APC tropism, use of the TAP-independent processing pathway, and dependency on CD80/CD86 costimulationNadeem A Sheikh, George S Attard, Nico van Rooijen, et al.
Pageof 2